Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07118813

Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment

Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment (AI-Kidney-Prognosis)

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective observational cohort study (AI-Kidney-Prognosis), aiming to non-invasively predict the clinical outcomes in renal cell carcinoma patients after surgical treatment using radiomics-based AI models, thereby assisting clinical decision-making and personalized follow-up strategies.

Conditions

Timeline

Start date
2025-08-01
Primary completion
2026-08-01
Completion
2026-08-01
First posted
2025-08-12
Last updated
2025-08-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07118813. Inclusion in this directory is not an endorsement.

Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surg (NCT07118813) · Clinical Trials Directory